Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.

Modesto A, Tougeron D, Tremolières P, Ronchin P, Jouve AD, Leignel DA, Vendrely V, Riou O, Martin-Babau J, Le Sourd S, Mirabel X, Leroy T, Huguet F, Montaigne L, Baumgaertner I, Deslandres M, Moyal E, Seva C, Selves J, Otal P, Pezzella V, Guimbaud R, Filleron T, Quéro L

Open source

DOI: 10.1186/s12885-023-11227-0
Published: 2023 Oct 12
Container: BMC cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-023-11227-0,
  title = {Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.},
  author = {Modesto A and Tougeron D and Tremolières P and Ronchin P and Jouve AD and Leignel DA and Vendrely V and Riou O and Martin-Babau J and Le Sourd S and Mirabel X and Leroy T and Huguet F and Montaigne L and Baumgaertner I and Deslandres M and Moyal E and Seva C and Selves J and Otal P and Pezzella V and Guimbaud R and Filleron T and Quéro L},
  year = {2023},
  journal = {BMC cancer},
  doi = {10.1186/s12885-023-11227-0},
  url = {https://doi.org/10.1186/s12885-023-11227-0}
}

RIS

TY  - JOUR
TI  - Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
AU  - Modesto A
AU  - Tougeron D
AU  - Tremolières P
AU  - Ronchin P
AU  - Jouve AD
AU  - Leignel DA
AU  - Vendrely V
AU  - Riou O
AU  - Martin-Babau J
AU  - Le Sourd S
AU  - Mirabel X
AU  - Leroy T
AU  - Huguet F
AU  - Montaigne L
AU  - Baumgaertner I
AU  - Deslandres M
AU  - Moyal E
AU  - Seva C
AU  - Selves J
AU  - Otal P
AU  - Pezzella V
AU  - Guimbaud R
AU  - Filleron T
AU  - Quéro L
PY  - 2023
JO  - BMC cancer
DO  - 10.1186/s12885-023-11227-0
UR  - https://doi.org/10.1186/s12885-023-11227-0
ER  -

APA

A, M., D, T., P, T., P, R., AD, J., DA, L., V, V., O, R., J, M., S, L. S., X, M., T, L., F, H., L, M., I, B., M, D., E, M., C, S., J, S., P, O., V, P., R, G., T, F., & L, Q. (2023). Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.. BMC cancer. https://doi.org/10.1186/s12885-023-11227-0

Source records

pubmed · retrieved 2026-09-26T20:27:50.622Z